Margo De Velder Faculty of Pharmaceutical Sciences > Department of Pharmaceutics 1 – 3 of 3 publications Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Download search results Subscribe to news feed Add to list Journal Article A1 open access Gentle and efficient engineering of primary human NK cells by photoporation with polydopamine nanosensitizers Charlotte Hinnekens (UGent) , Jana Ramon (UGent) , M. Birben, W.T.V. Germeraad, A. Harizaj, Margo De Velder (UGent) , Stefaan De Smedt (UGent) , Bart Vandekerckhove (UGent) , Kevin Braeckmans (UGent) and Juan Fraire (UGent) (2025) JOURNAL OF CONTROLLED RELEASE. 382. Add to list Journal Article A1 open access Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs Sofie Meulewaeter (UGent) , Margo De Velder (UGent) , Diethard Reckelbus (UGent) , Kevin Mwangi (UGent) , Thomas Ehouarne (UGent) , Ilke Aernout (UGent) , Yanou Engelen (UGent) , Fëllanza Halimi (UGent) , Isis Van herteryck (UGent) , Lobke De Bels (UGent) , et al. (2025) MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT. 33(2). Add to list Journal Article A1 open access Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria Sofie Meulewaeter (UGent) , Ilke Aernout (UGent) , Joke Deprez (UGent) , Yanou Engelen (UGent) , Margo De Velder (UGent) , Lorenzo Franceschini, Karine Breckpot, Serge Van Calenbergh (UGent) , Caroline Asselman (UGent) , Katie Boucher (UGent) , et al. (2024) JOURNAL OF CONTROLLED RELEASE. 370. p.379-391
